Global Pharmaceutical Lysozyme Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Pharmaceutical Lysozyme market size was valued at US$ 43.8 million in 2024 and is forecast to a readjusted size of USD 59.5 million by 2031 with a CAGR of 4.5% during review period.
Pharmaceutical Lysozyme is an enzyme that is naturally present in various bodily fluids, including tears, saliva, and mucus. It plays a crucial role in the immune system as a defense mechanism against bacterial infections. Lysozyme works by breaking down the bacterial cell walls, leading to the destruction of the bacteria.
Lysozyme, can be manufactured by egg white or microbial fermentation. Presently, feed grade lysozyme is mainly produced via microbial fermentation, while lysozyme made from egg white is widely used in food industry, pharma industry, etc. Enzyme activity is a very key indicator for pharmaceutical lysozyme. The much higher the activity of lysozyme is, the more expensive of its price.
Major production of pharmaceutical plysozyme is distributed in Europe. Bioseutica and Bouwhuis Enthoven are representatives of the industry.
The market for pharmaceutical plysozyme is influenced by several key drivers:
Antimicrobial Properties: Lysozyme's effectiveness against bacteria makes it valuable in pharmaceuticals, particularly in formulations aimed at treating infections or as preservatives in medications.
Rising Incidence of Infectious Diseases: The growing prevalence of bacterial infections boosts the demand for effective antimicrobial agents, including lysozyme.
Pharmaceutical Innovations: The development of new formulations that incorporate lysozyme can expand its applications, particularly in innovative drug delivery methods.
This report is a detailed and comprehensive analysis for global Pharmaceutical Lysozyme market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Lysozyme market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Pharmaceutical Lysozyme market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Pharmaceutical Lysozyme market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Pharmaceutical Lysozyme market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Lysozyme
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Lysozyme market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioseutica, Bouwhuis Enthoven, EPS S.P.A, Kewpie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Lysozyme market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lysozyme Solution
Lysozyme Powder
Market segment by Application
Nasal and Throat Preparations
Dental Care
Other
Major players covered
Bioseutica
Bouwhuis Enthoven
EPS S.P.A
Kewpie
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Lysozyme product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Lysozyme, with price, sales quantity, revenue, and global market share of Pharmaceutical Lysozyme from 2020 to 2025.
Chapter 3, the Pharmaceutical Lysozyme competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Lysozyme breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Lysozyme market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Lysozyme.
Chapter 14 and 15, to describe Pharmaceutical Lysozyme sales channel, distributors, customers, research findings and conclusion.
Pharmaceutical Lysozyme is an enzyme that is naturally present in various bodily fluids, including tears, saliva, and mucus. It plays a crucial role in the immune system as a defense mechanism against bacterial infections. Lysozyme works by breaking down the bacterial cell walls, leading to the destruction of the bacteria.
Lysozyme, can be manufactured by egg white or microbial fermentation. Presently, feed grade lysozyme is mainly produced via microbial fermentation, while lysozyme made from egg white is widely used in food industry, pharma industry, etc. Enzyme activity is a very key indicator for pharmaceutical lysozyme. The much higher the activity of lysozyme is, the more expensive of its price.
Major production of pharmaceutical plysozyme is distributed in Europe. Bioseutica and Bouwhuis Enthoven are representatives of the industry.
The market for pharmaceutical plysozyme is influenced by several key drivers:
Antimicrobial Properties: Lysozyme's effectiveness against bacteria makes it valuable in pharmaceuticals, particularly in formulations aimed at treating infections or as preservatives in medications.
Rising Incidence of Infectious Diseases: The growing prevalence of bacterial infections boosts the demand for effective antimicrobial agents, including lysozyme.
Pharmaceutical Innovations: The development of new formulations that incorporate lysozyme can expand its applications, particularly in innovative drug delivery methods.
This report is a detailed and comprehensive analysis for global Pharmaceutical Lysozyme market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Lysozyme market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Pharmaceutical Lysozyme market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Pharmaceutical Lysozyme market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Pharmaceutical Lysozyme market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Lysozyme
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Lysozyme market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioseutica, Bouwhuis Enthoven, EPS S.P.A, Kewpie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Lysozyme market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lysozyme Solution
Lysozyme Powder
Market segment by Application
Nasal and Throat Preparations
Dental Care
Other
Major players covered
Bioseutica
Bouwhuis Enthoven
EPS S.P.A
Kewpie
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Lysozyme product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Lysozyme, with price, sales quantity, revenue, and global market share of Pharmaceutical Lysozyme from 2020 to 2025.
Chapter 3, the Pharmaceutical Lysozyme competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Lysozyme breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Lysozyme market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Lysozyme.
Chapter 14 and 15, to describe Pharmaceutical Lysozyme sales channel, distributors, customers, research findings and conclusion.
Table of Contents
72 Pages
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pharmaceutical Lysozyme Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Lysozyme Solution
- 1.3.3 Lysozyme Powder
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Pharmaceutical Lysozyme Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Nasal and Throat Preparations
- 1.4.3 Dental Care
- 1.4.4 Other
- 1.5 Global Pharmaceutical Lysozyme Market Size & Forecast
- 1.5.1 Global Pharmaceutical Lysozyme Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Pharmaceutical Lysozyme Sales Quantity (2020-2031)
- 1.5.3 Global Pharmaceutical Lysozyme Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Bioseutica
- 2.1.1 Bioseutica Details
- 2.1.2 Bioseutica Major Business
- 2.1.3 Bioseutica Pharmaceutical Lysozyme Product and Services
- 2.1.4 Bioseutica Pharmaceutical Lysozyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Bioseutica Recent Developments/Updates
- 2.2 Bouwhuis Enthoven
- 2.2.1 Bouwhuis Enthoven Details
- 2.2.2 Bouwhuis Enthoven Major Business
- 2.2.3 Bouwhuis Enthoven Pharmaceutical Lysozyme Product and Services
- 2.2.4 Bouwhuis Enthoven Pharmaceutical Lysozyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Bouwhuis Enthoven Recent Developments/Updates
- 2.3 EPS S.P.A
- 2.3.1 EPS S.P.A Details
- 2.3.2 EPS S.P.A Major Business
- 2.3.3 EPS S.P.A Pharmaceutical Lysozyme Product and Services
- 2.3.4 EPS S.P.A Pharmaceutical Lysozyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 EPS S.P.A Recent Developments/Updates
- 2.4 Kewpie
- 2.4.1 Kewpie Details
- 2.4.2 Kewpie Major Business
- 2.4.3 Kewpie Pharmaceutical Lysozyme Product and Services
- 2.4.4 Kewpie Pharmaceutical Lysozyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Kewpie Recent Developments/Updates
- 3 Competitive Environment: Pharmaceutical Lysozyme by Manufacturer
- 3.1 Global Pharmaceutical Lysozyme Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Pharmaceutical Lysozyme Revenue by Manufacturer (2020-2025)
- 3.3 Global Pharmaceutical Lysozyme Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Pharmaceutical Lysozyme by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Pharmaceutical Lysozyme Manufacturer Market Share in 2024
- 3.4.3 Top 6 Pharmaceutical Lysozyme Manufacturer Market Share in 2024
- 3.5 Pharmaceutical Lysozyme Market: Overall Company Footprint Analysis
- 3.5.1 Pharmaceutical Lysozyme Market: Region Footprint
- 3.5.2 Pharmaceutical Lysozyme Market: Company Product Type Footprint
- 3.5.3 Pharmaceutical Lysozyme Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Pharmaceutical Lysozyme Market Size by Region
- 4.1.1 Global Pharmaceutical Lysozyme Sales Quantity by Region (2020-2031)
- 4.1.2 Global Pharmaceutical Lysozyme Consumption Value by Region (2020-2031)
- 4.1.3 Global Pharmaceutical Lysozyme Average Price by Region (2020-2031)
- 4.2 North America Pharmaceutical Lysozyme Consumption Value (2020-2031)
- 4.3 Europe Pharmaceutical Lysozyme Consumption Value (2020-2031)
- 4.4 Asia-Pacific Pharmaceutical Lysozyme Consumption Value (2020-2031)
- 4.5 South America Pharmaceutical Lysozyme Consumption Value (2020-2031)
- 4.6 Middle East & Africa Pharmaceutical Lysozyme Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Pharmaceutical Lysozyme Sales Quantity by Type (2020-2031)
- 5.2 Global Pharmaceutical Lysozyme Consumption Value by Type (2020-2031)
- 5.3 Global Pharmaceutical Lysozyme Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Pharmaceutical Lysozyme Sales Quantity by Application (2020-2031)
- 6.2 Global Pharmaceutical Lysozyme Consumption Value by Application (2020-2031)
- 6.3 Global Pharmaceutical Lysozyme Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Pharmaceutical Lysozyme Sales Quantity by Type (2020-2031)
- 7.2 North America Pharmaceutical Lysozyme Sales Quantity by Application (2020-2031)
- 7.3 North America Pharmaceutical Lysozyme Market Size by Country
- 7.3.1 North America Pharmaceutical Lysozyme Sales Quantity by Country (2020-2031)
- 7.3.2 North America Pharmaceutical Lysozyme Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Pharmaceutical Lysozyme Sales Quantity by Type (2020-2031)
- 8.2 Europe Pharmaceutical Lysozyme Sales Quantity by Application (2020-2031)
- 8.3 Europe Pharmaceutical Lysozyme Market Size by Country
- 8.3.1 Europe Pharmaceutical Lysozyme Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Pharmaceutical Lysozyme Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Lysozyme Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Pharmaceutical Lysozyme Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Pharmaceutical Lysozyme Market Size by Region
- 9.3.1 Asia-Pacific Pharmaceutical Lysozyme Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Pharmaceutical Lysozyme Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Pharmaceutical Lysozyme Sales Quantity by Type (2020-2031)
- 10.2 South America Pharmaceutical Lysozyme Sales Quantity by Application (2020-2031)
- 10.3 South America Pharmaceutical Lysozyme Market Size by Country
- 10.3.1 South America Pharmaceutical Lysozyme Sales Quantity by Country (2020-2031)
- 10.3.2 South America Pharmaceutical Lysozyme Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Lysozyme Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Pharmaceutical Lysozyme Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Pharmaceutical Lysozyme Market Size by Country
- 11.3.1 Middle East & Africa Pharmaceutical Lysozyme Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Pharmaceutical Lysozyme Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Pharmaceutical Lysozyme Market Drivers
- 12.2 Pharmaceutical Lysozyme Market Restraints
- 12.3 Pharmaceutical Lysozyme Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Pharmaceutical Lysozyme and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pharmaceutical Lysozyme
- 13.3 Pharmaceutical Lysozyme Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pharmaceutical Lysozyme Typical Distributors
- 14.3 Pharmaceutical Lysozyme Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
